Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2014 Aug 18.

Published in final edited form as: Thorax. 2011 Nov 16;67(4):309–314. doi: 10.1136/thoraxjnl-2011-200702

Table 2.

Characteristics of HIV-infected participants

	OLD absent	OLD present	p Value
N	252	51	0.79
CD4 count, n (%)^*
<100 cells/mm³	25 (10)	5 (9)	0.66
100–199 cells/mm³	41 (16)	11 (22)
200–349 cells/mm³	73 (29)	11 (22)
>350 cells/mm³	113 (45)	24 (47)
CD8 count, n (%)^*
<500 cells/mm³	64 (25)	10 (19)	0.11
500–1000 cells/mm³	123 (49)	33 (65)
>1000 cells/mm³	65 (26)	8 (16)
HIV RNA level, n (%)^*
<400 copies/ml	118 (47)	25 (49)	0.02
400–200 000 copies/ml	123 (49)	19 (37)
>200 000 copies/ml	11 (4)	7 (14)
HIV RNA (log₁₀ copies/ml)^* ^†	4.33 (3.65–4.76)	4.23 (3.18–5.33)	0.91
ART use ever, n (%)^*	177 (70)	33 (65)	0.46
ART use in prior 6 months, n (%)^*	143 (57)	26 (51)	0.45
Anti-Pneumocystis therapy, n (%)^* ^‡	82 (32)	19 (37)	0.52
Pneumonia, n (%)
Bacterial	93 (10)	34 (19)	0.001
Pneumocystis	13 (1)	3 (2)	0.79

Values presented as median (IQR) unless indicated otherwise.

^*

Median (IQR) or n (%) of HIV-infected participants only.

^†

Among HIV-infected individuals with detectable viral load. Five individuals in the ‘OLD Absent’ group have missing viral load/antiretroviral data.

^‡

In prior 6 months.

ART, antiretroviral therapy; CD4, CD4 Th cells; OLD, obstructive lung disease.